6-46625433-C-G
Variant summary
Our verdict is Uncertain significance. Variant got 3 ACMG points: 3P and 0B. PM2PP3
The NM_016593.5(CYP39A1):c.916G>C(p.Val306Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_016593.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 3 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CYP39A1 | ENST00000275016.3 | c.916G>C | p.Val306Leu | missense_variant | Exon 7 of 12 | 1 | NM_016593.5 | ENSP00000275016.2 | ||
CYP39A1 | ENST00000619708.4 | c.400G>C | p.Val134Leu | missense_variant | Exon 6 of 11 | 1 | ENSP00000477769.1 | |||
CYP39A1 | ENST00000480804.1 | n.227G>C | non_coding_transcript_exon_variant | Exon 3 of 5 | 5 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 29
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.916G>C (p.V306L) alteration is located in exon 7 (coding exon 7) of the CYP39A1 gene. This alteration results from a G to C substitution at nucleotide position 916, causing the valine (V) at amino acid position 306 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at